KESPF yields 2500.00% · JNJ yields 2.13%● Live data
📍 KESPF pulled ahead of the other in Year 1
Combined, KESPF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KESPF + JNJ for your $10,000?
Kleos Space S.A., together with its subsidiaries, engages in the development of the space enabled, activity-based intelligence, and data-as-a-service (DaaS) products in Luxembourg and internationally. It offers activity-based intelligence and geolocation-as-a-service to guard borders, protect assets, and save lives. The company also provides Kleos Scouting Mission, a space satellite system; and researches and develops radio frequency (RF) geolocation and signal analysis techniques, as well as data science techniques, including machine learning, satellite technologies, and data processing methodologies solutions. It offers DaaS products to defence and security intelligence surveillance and reconnaissance markets, as well as to perform the tests on the equipment for launching low earth orbit (LEO) nano-satellite earth observation. The company was formerly known as Kleos Space S.à r.l. Kleos Space S.A. was incorporated in 2017 and is based in Luxembourg, Luxembourg.
Full KESPF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.